190 related articles for article (PubMed ID: 28754558)
1. Magnetic resonance T2 mapping and diffusion-weighted imaging for early detection of cystogenesis and response to therapy in a mouse model of polycystic kidney disease.
Franke M; Baeßler B; Vechtel J; Dafinger C; Höhne M; Borgal L; Göbel H; Koerber F; Maintz D; Benzing T; Schermer B; Persigehl T
Kidney Int; 2017 Dec; 92(6):1544-1554. PubMed ID: 28754558
[TBL] [Abstract][Full Text] [Related]
2. T2 relaxation time and apparent diffusion coefficient for noninvasive assessment of renal pathology after acute kidney injury in mice: comparison with histopathology.
Hueper K; Rong S; Gutberlet M; Hartung D; Mengel M; Lu X; Haller H; Wacker F; Meier M; Gueler F
Invest Radiol; 2013 Dec; 48(12):834-42. PubMed ID: 23907103
[TBL] [Abstract][Full Text] [Related]
3. Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury.
Aihara M; Fujiki H; Mizuguchi H; Hattori K; Ohmoto K; Ishikawa M; Nagano K; Yamamura Y
J Pharmacol Exp Ther; 2014 May; 349(2):258-67. PubMed ID: 24570071
[TBL] [Abstract][Full Text] [Related]
4. Severity of polycystic kidney disease revealed by multiparametric MRI.
Wang F; Lee SY; Adelnia F; Takahashi K; Harkins KD; He L; Zu Z; Ellinger P; Grundmann M; Harris RC; Takahashi T; Gore JC
Magn Reson Med; 2023 Sep; 90(3):1151-1165. PubMed ID: 37093746
[TBL] [Abstract][Full Text] [Related]
5. Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD.
Caroli A; Villa G; Brambilla P; Trillini M; Sharma K; Sironi S; Remuzzi G; Perico N; Remuzzi A
Eur Radiol; 2023 Sep; 33(9):6009-6019. PubMed ID: 37017703
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound detection and characterization of polycystic kidney disease in a mouse model.
Pollard R; Yunis R; Kültz D; Martin P; Griffey S; Ferrara K
Comp Med; 2006 Jun; 56(3):215-21. PubMed ID: 16774131
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
Bukanov NO; Smith LA; Klinger KW; Ledbetter SR; Ibraghimov-Beskrovnaya O
Nature; 2006 Dec; 444(7121):949-52. PubMed ID: 17122773
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging assessment of a murine model of recessive polycystic kidney disease.
Sun Y; Zhou J; Stayner C; Munasinghe J; Shen X; Beier DR; Albert MS
Comp Med; 2002 Oct; 52(5):433-8. PubMed ID: 12405636
[TBL] [Abstract][Full Text] [Related]
9. High-resolution genetic localization of a modifying locus affecting disease severity in the juvenile cystic kidneys (jck) mouse model of polycystic kidney disease.
Beier DR
Mamm Genome; 2016 Jun; 27(5-6):191-9. PubMed ID: 27114383
[TBL] [Abstract][Full Text] [Related]
10. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.
Smith LA; Bukanov NO; Husson H; Russo RJ; Barry TC; Taylor AL; Beier DR; Ibraghimov-Beskrovnaya O
J Am Soc Nephrol; 2006 Oct; 17(10):2821-31. PubMed ID: 16928806
[TBL] [Abstract][Full Text] [Related]
11. The role of serum E-selectin level and E-selectin gene S128R polymorphism on the enlargement of renal cyst in patients with polycystic kidney disease: Genetic background of renal cyst growth
.
Esen B; Sayin T; Akbas H; Gokmen ES; Atay AE; Guzel SP; Gorgulu N; Yavuz DG
Clin Nephrol; 2020 Jan; 93(1):34-49. PubMed ID: 31746731
[TBL] [Abstract][Full Text] [Related]
12. Polycystic kidney disease evaluation by magnetic resonance imaging in ischemia-reperfusion injured PKD1 knockout mouse model: comparison of T2-weighted FSE and true-FISP.
Zhou X; Bao H; Takakura A; Zhou J; Albert M; Sun Y
Invest Radiol; 2010 Jan; 45(1):24-8. PubMed ID: 19996760
[TBL] [Abstract][Full Text] [Related]
13. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.
Natoli TA; Gareski TC; Dackowski WR; Smith L; Bukanov NO; Russo RJ; Husson H; Matthews D; Piepenhagen P; Ibraghimov-Beskrovnaya O
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F73-83. PubMed ID: 17928412
[TBL] [Abstract][Full Text] [Related]
14. Impact of measurement parameters on apparent diffusion coefficient quantification in diffusion-weighted-magnetic resonance imaging.
Schmidt H; Gatidis S; Schwenzer NF; Martirosian P
Invest Radiol; 2015 Jan; 50(1):46-56. PubMed ID: 25247326
[TBL] [Abstract][Full Text] [Related]
15. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner.
Sadick M; Schock D; Kraenzlin B; Gretz N; Schoenberg SO; Michaely HJ
Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861
[TBL] [Abstract][Full Text] [Related]
16. CystAnalyser: A new software tool for the automatic detection and quantification of cysts in Polycystic Kidney and Liver Disease, and other cystic disorders.
Cordido A; Cernadas E; Fernández-Delgado M; García-González MA
PLoS Comput Biol; 2020 Oct; 16(10):e1008337. PubMed ID: 33090995
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
18. Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease.
Natoli TA; Husson H; Rogers KA; Smith LA; Wang B; Budman Y; Bukanov NO; Ledbetter SR; Klinger KW; Leonard JP; Ibraghimov-Beskrovnaya O
Hum Mol Genet; 2012 Aug; 21(15):3397-407. PubMed ID: 22563011
[TBL] [Abstract][Full Text] [Related]
19. Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.
Husson H; Moreno S; Smith LA; Smith MM; Russo RJ; Pitstick R; Sergeev M; Ledbetter SR; Bukanov NO; Lane M; Zhang K; Billot K; Carlson G; Shah J; Meijer L; Beier DR; Ibraghimov-Beskrovnaya O
Hum Mol Genet; 2016 Jun; 25(11):2245-2255. PubMed ID: 27053712
[TBL] [Abstract][Full Text] [Related]
20. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
